Legislative Activity

This bill terminates the Department of Education, effectively eliminating the department on December 31, 2026.

The "Stop Illegal Reentry Act" increases the penalties for individuals who illegally reenter the United States after having been deported or removed. It raises the maximum prison sentence for general illegal reentry to five years. Repeat offenders or those with prior felony convictions could face up to 10 years, and aggravated felons or repeat re-entrants could face a mandatory minimum of five years and up to 20 years in prison.

Recognizes and supports Catholic schools in the United States for their academic excellence, diverse communities, and values-based education. Designates January 26, 2025, to February 1, 2025, as National Catholic Schools Week, celebrating the commitment of Catholic schools, students, parents, and teachers to academic excellence and community service.

The "Achieving Choice in Education Act" (ACE Act) expands the use of 529 savings accounts to cover a broader range of educational expenses, including homeschooling costs, and increases the distribution limit for elementary and secondary education. The act also raises the gift tax exclusion for 529 plan contributions and restricts tax-exempt bond eligibility to states that have implemented certain school choice programs meeting specific criteria for student eligibility and funding. These school choice programs include tax credit scholarship programs, voucher programs, education savings accounts, and refundable tax credits for private education expenses.

The "PROTECTS Act of 2025" prohibits federal funds from being used for gender transition procedures for individuals under 18, including surgeries and hormone therapies, with exceptions for certain medical conditions and genetic disorders. The bill defines "sex" as biologically determined male or female based on reproductive systems.

The "287(g) Program Protection Act" amends the Immigration and Nationality Act to mandate that the Department of Homeland Security (DHS) enter into agreements with states and their subdivisions, enabling their law enforcement officers to perform certain immigration enforcement functions, provided they meet DHS standards. It requires DHS to justify denials of state requests, prohibits limits on the number of agreements, and ensures agreements accommodate various enforcement models preferred by the states. The Act also establishes appeal processes for agreement terminations, mandates uniform training standards, and directs DHS to publish annual performance reports and recruitment plans for the 287(g) program.

The "Parental Notification and Intervention Act of 2025" requires parental notification before an abortion can be performed on an unemancipated minor, with exceptions for medical emergencies or court waivers. It allows parents to sue in federal court to stop an abortion from occurring. States can enact stricter parental notification or intervention laws. The act would take effect immediately upon becoming law.

The "Personalized Care Act of 2025" expands Health Savings Account (HSA) eligibility, increases contribution limits, and allows HSA funds to be used for a broader range of healthcare expenses, including health plan premiums and healthcare sharing ministry fees. It also reduces the penalty for non-qualified HSA distributions and clarifies the treatment of medical care service arrangements and periodic provider fees. These changes aim to provide individuals with greater flexibility and control over their healthcare spending and coverage.

The "Charitable Act" modifies the tax deduction for charitable contributions for individuals who do not itemize deductions. For the 2026 and 2027 tax years, the deduction will be capped at one-third of the standard deduction amount for the individual. The Act also eliminates and redesignates certain penalty clauses in the Internal Revenue Code related to these deductions, updating references accordingly.

The "Pregnancy Is Not an Illness Act of 2025" prevents the Department of Health and Human Services from classifying pregnancy as an illness when approving abortion drugs or setting risk management strategies for these drugs. It invalidates any prior abortion drug approvals that were based on classifying pregnancy as an illness, including the approval of mifepristone.

The "Second Chance for Moms Act of 2025" requires a warning label on mifepristone indicating its effects may be reversed with progesterone, potentially increasing fetal survival, and provides a hotline number for further information. It also directs the Secretary to establish a 24/7 toll-free hotline for women seeking to reverse the effects of mifepristone, offering referrals exclusively to healthcare providers who offer abortion pill reversal.

The "Safeguarding American Workers Benefits Act" amends the Internal Revenue Code to modify Social Security number (SSN) requirements for the Child Tax Credit and the Earned Income Tax Credit. It mandates that to claim these credits, the SSN must be issued by the Social Security Administration to a U.S. citizen or someone authorized to work in the U.S. These modifications will be effective for taxable years beginning after December 31, 2025.

The "Dignity for Aborted Children Act" requires abortion providers to offer patients the option to take possession of fetal remains for burial or cremation, or to have the provider arrange for interment or cremation. Abortion providers must obtain consent, maintain records, and submit annual reports on abortion procedures and fetal tissue disposal. Non-compliance can result in significant penalties, but patients are protected from prosecution.

The "Life at Conception Act" declares that the right to life, as guaranteed by the Constitution, is vested in each human being, both born and preborn, from fertilization onward. This act defines "human being" as every member of the species homo sapiens at all stages of life. Notably, the act specifies that no woman shall be prosecuted for the death of her unborn child.

The "Protecting Life in Health Savings Accounts Act" restricts the use of Health Savings Accounts (HSAs) and similar health accounts for abortion expenses, starting in 2026. It provides exceptions for abortions in cases of rape, incest, or to save the woman's life, with physician certification required.

The "No Abortion Coverage for Medicaid Act" seeks to codify the Hyde Amendment by ensuring that federal Medicaid funds are not used for abortions or health coverage that includes abortion services. This includes prohibiting the use of federal funds for travel or lodging related to obtaining an abortion. Exceptions are made only in cases of rape, incest, to save the mother's life, or for the treatment of a miscarriage or ectopic pregnancy.

The "Born-Alive Abortion Survivors Protection Act" ensures that infants born alive after an abortion receive the same medical care as any other newborn, mandating immediate hospitalization and requiring healthcare practitioners to report any failures to comply. Violators face fines, imprisonment, and potential prosecution for homicide or attempted homicide, while the mother of the child cannot be prosecuted. The bill also allows the woman who had the abortion to file a civil action against anyone who violated the act. It defines abortion and attempts at abortion, and renames "Partial-Birth Abortions" to "Abortions" in relevant sections of the U.S. Code.

This bill nullifies the FDA's January 2023 modifications to the risk evaluation and mitigation strategy (REMS) for mifepristone, an abortion pill. It also prevents the Secretary of Health and Human Services from creating or enforcing similar regulations related to mifepristone's distribution.

The "Main Street Tax Certainty Act" amends the Internal Revenue Code of 1986 to permanently extend the deduction for qualified business income. This removes the previous expiration date, providing long-term tax certainty for eligible businesses. The change applies to taxable years beginning after December 31, 2025.

The "SAVE Moms and Babies Act of 2025" prohibits the approval of new abortion drugs and restricts the use of previously approved abortion drugs by limiting label changes, mandating in-person dispensing by certified healthcare practitioners, and requiring comprehensive reporting of adverse events. It defines key terms such as "abortion drug," "adverse event," and "unborn child," and it rescinds conflicting investigational use exemptions three years after enactment. This bill aims to ensure patient safety and regulatory oversight in the use of abortion drugs.